Advanced in Leukemia

Peihua H. Lu

Langfang, CN 
Advanced in Leukemia
Langfang, CN 
OverviewLocationsClinical Research

Overview

Peihua Lu practices in Langfang, China. Lu is rated as an Advanced expert by MediFind in the treatment of Leukemia. Their top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Adult T-Cell Leukemia, Leukemia, Acute Promyelocytic Leukemia, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 47 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 28 articles and participated in 1 clinical trial in the study of Leukemia.

Locations

Langfang, China
Other Locations
Beijing, China
Hebei, China
Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized, Parallel-arm, Controlled Trial of Senl_1904A and Senl_1904B Autologous CAR-T Cell Injections in the Treatment of Relapsed and Refractory Acute B Lymphocytic Leukemia(r/r B-ALL)
Randomized, Parallel-arm, Controlled Trial of Senl_1904A and Senl_1904B Autologous CAR-T Cell Injections in the Treatment of Relapsed and Refractory Acute B Lymphocytic Leukemia(r/r B-ALL)
Enrollment Status: Unknown
Publish Date: January 20, 2021
Intervention Type: Biological
Study Drug: Autologous CD19-targeting CAR T cells
Study Phase: Phase 1

47 Total Publications

The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry.
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry.
Journal: Clinical transplantation
Published: June 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lu's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile